Blood and Tissue Sample Collection for Future Colon Cancer Biomarker Studies in Patients Undergoing Colonoscopy
Discovery of Candidate Biomarkers in Colon Cancer and Precancers Repository
4 other identifiers
observational
6,446
1 country
4
Brief Summary
RATIONALE: Collecting and storing samples of blood and tissue from patients undergoing colonoscopy to study in the laboratory may help doctors learn more about colon cancer and identify biomarkers related to colon cancer in the future. PURPOSE: This laboratory study is collecting blood and tissue samples for future colon cancer biomarker studies in patients undergoing colonoscopy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2006
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2006
CompletedFirst Submitted
Initial submission to the registry
May 9, 2009
CompletedFirst Posted
Study publicly available on registry
May 12, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2016
CompletedApril 7, 2017
April 1, 2017
8.7 years
May 9, 2009
April 5, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Collection of blood and tissue
Pre-op & during surgery
Interventions
Eligibility Criteria
Patients scheduled for colonoscopy either as routine screening or for a specific problem.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Vanderbilt Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (4)
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, 37064, United States
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, 37064, United States
Dan Rudy Cancer Center at Saint Thomas Hospital
Nashville, Tennessee, 37205, United States
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232-6838, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Daniel C. Liebler, PhD
Vanderbilt-Ingram Cancer Center
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Adjunct Professor
Study Record Dates
First Submitted
May 9, 2009
First Posted
May 12, 2009
Study Start
December 1, 2006
Primary Completion
August 1, 2015
Study Completion
April 1, 2016
Last Updated
April 7, 2017
Record last verified: 2017-04